Patent details

Basic Information

Publication number:

92311

Type:

SPC

SPC Type:

Medical

Basic Patent Number:

EP019917533

Legal Status:

Active

Application number:

92311

First applicant's nationality:

Procedural language:

French

Marketing Authorization

Marketing Authorization Number:

EU/1/13/855/001 - IMVANEX

Marketing Authorization Type:

Marketing Authorization Date:

31/07/2013

Marketing Authorization Status:

Accepted

Marketing Authorization Country:

Dates

Filing date:

20/11/2013

First Marketing Authorization date:

31/07/2013

Grant date:

20/01/2014

Activation date:

22/11/2021

Publication date:

20/01/2014

Lapsed date:

Expiration date:

Renunciation date:

Revocation date:

Annulment date:

Basic SPC Expiration:

22/11/2026

SPC Extension Expiration:

22/11/2026

Rejection date:

Withdrawal date:

Owner

From:

16/06/2017

 

 

Name:

BAVARIAN NORDIC A/S

Address:

HEJRESKOVVEJ 10 A, 3490, KVISTGAARD, Denmark (DK)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

20/11/2013

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

CHAPLIN Paul

Address:

Germany (DE)

2

Name:

MEISINGER Christine

Address:

Germany (DE)

3

Name:

HOWLEY Paul

Address:

Germany (DE)

Publication

Bulletin

Bulletin Heading:

SPC3

Bulletin edition number:

2021/13

Publication date:

02/12/2021

Description:

Section E : Supplementary Protection certificates entered into force – IA publication

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

13/11/2025

Last Annual Fee Paid Number:

25

Last Annual Fee Paid Amount:

450 Euro

Payer:

CPA GLOBAL THE IP PLATFORM

Filing date	Document type	Number of pages
26/06/2017	Outgoing Correspondence	1
16/06/2017	Request For Change	1